A. Muraishi et al., Malalignment of the sarcomeric filaments in hypertrophic cardiomyopathy with cardiac myosin heavy chain gene mutation, HEART, 82(5), 1999, pp. 625-629
Citations number
18
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective-To investigate changes in the alignment of the sarcomeric filamen
ts in hypertrophic cardiomyopathy and the effects of cardiac beta myosin he
avy chain (beta-MHC) mutation on the sarcomeric ultrastructure.
Design-A retrospective analysis.
Patients-Endomyocardial biopsy samples were examined by transmission electr
on microscopy in seven patients with hypertrophic cardiomyopathy and beta-M
HC mutation, six with hypertrophic cardiomyopathy but without the mutation,
and five controls (with chest pain syndromes).
Main outcome measure-Alignment of the sarcomeric filaments and the distance
between neighbouring thick myosin filaments.
Results-In controls, cross sections of the sarcomere at the A band showed a
highly organised orthohexagonal array with 6 thin actin filaments surround
ing one thick myosin filament, whereas in hypertrophic cardiomyopathy the a
lignment of the sarcomeric filaments was sparse and disrupted. In hypertrop
hic cardiomyopathy with a mutation, the distance between neighbouring thick
myosin filaments was greater than in controls (mean (SD) 45.3 (4.7) v 38.5
(3.5) nm, p < 0.05), and the variance of the distance was greater than in
controls (8.0 (0.7) v 4.8 (1.0) nm, p < 0.001) or in patients with hypertro
phic cardiomyopathy without a mutation (6.7 (0.6) nm, p < 0.05). In the lat
ter, the variance of the distance was also greater than in the controls (p
< 0.01). A significant correlation was found between the grade of the myocy
te hypertrophy and the variance of the distance (r = 0.654; p < 0.01).
Conclusions-The alignment of the sarcomeric filaments is disrupted in hyper
trophic cardiomyopathy, particularly when there is beta-MHC mutation.